News stories about Fluidigm Corporation (NASDAQ:FLDM) have trended somewhat positive on Monday, according to Accern. The research group identifies negative and positive news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Fluidigm Corporation earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news articles about the medical research company an impact score of 45.2962233040768 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Separately, ValuEngine lowered shares of Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a research report on Thursday.

Fluidigm Corporation (FLDM) traded up $0.02 during trading hours on Monday, hitting $5.24. 110,400 shares of the stock were exchanged, compared to its average volume of 260,234. The company has a quick ratio of 2.46, a current ratio of 3.02 and a debt-to-equity ratio of 5.00. Fluidigm Corporation has a twelve month low of $2.52 and a twelve month high of $8.69.

In other news, insider Levin Capital Strategies, L.P. acquired 95,843 shares of the business’s stock in a transaction dated Tuesday, October 10th. The stock was acquired at an average price of $4.57 per share, with a total value of $438,002.51. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last three months, insiders bought 491,998 shares of company stock valued at $2,353,092. Company insiders own 4.70% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Stock Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related stocks with our FREE daily email newsletter.